UNSPSC 85764302: Revision of nonautologous tissue substitute in neck, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in neck, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0WW63KZ

UNSPSC 85764302 Revision of nonautologous tissue substitute in neck, percutaneous approach is a Commodity code that shows no recent state and local procurement activity aligned with its nominal medical-procedure scope. The six recent opportunities posted under this code span independent medical evaluations for public safety pension boards, surgical benefit carve-outs for municipal employees, occupational health surveillance, juvenile detention medical services, pharmacy benefit management, and temporary ancillary clinical staffing — none of which involve tissue revision procedures or percutaneous surgical techniques. This mismatch suggests the code has been assigned to these solicitations in error or reflects a data-classification anomaly in state and local procurement systems rather than genuine demand for the procedure named in the code.

Opportunities are scattered across dissimilar issuing bodies: the City of Phoenix Retirement Office (medical evaluation services for pension determinations), City of Long Beach (employee health plan surgery networks), Washington State Department of Transportation (occupational health for ferries employees), Harris County Juvenile Probation Department (detention health services), Collier County (pharmacy administration), and County of Santa Clara (temporary clinical staffing). Geographically, activity appears in Arizona, California, Washington, Florida, and Texas, with no clustering pattern. The code itself does not appear to drive meaningful procurement volume or vendor strategy at the state and local level; prospective vendors should verify with individual issuing bodies whether tissue-substitute procedures are actually being solicited, rather than rely on this commodity classification.